The total return over the past 12 months is +25.71% vs. +16.94% for the S&P 500. So far it's up -24.16% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +25.71% | +15.82% | (13.55%) | (19.77%) | N/A | N/A |
| Total Return CAGR | +25.71% | +15.82% | (13.55%) | (19.77%) | N/A | N/A |
| Revenue CAGR | N/A | +1498.63% | (18.12%) | +44.68% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
vTv Therapeutics Inc. (VTVT)
| Year | Start price | End price | VTVT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $39.99 | $30.33 | (24.16%) | +14.51% | (38.67%) |
| 2025 | $13.81 | $39.99 | +189.57% | +17.72% | +171.85% |
| 2024 | $11.50 | $13.81 | +20.09% | +24.89% | (4.80%) |
| 2023 | $26.52 | $11.50 | (56.64%) | +26.19% | (82.83%) |
| 2022 | $39.80 | $26.52 | (33.37%) | (18.17%) | (15.20%) |
| 2021 | $74.40 | $39.80 | (46.51%) | +28.74% | (75.25%) |
| 2020 | $68.00 | $74.40 | +9.41% | +18.37% | (8.96%) |
| 2019 | $106.00 | $68.00 | (35.85%) | +31.22% | (67.07%) |
| 2018 | $240.40 | $106.00 | (55.91%) | (4.56%) | (51.35%) |
| 2017 | $193.20 | $240.40 | +24.43% | +21.70% | +2.73% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
